Schizophrenia News and Research

Latest Schizophrenia News and Research

Psychosis prediction model could facilitate early intervention

A integrated model has shown “outstanding” ability to predict the transition to psychosis in clinically high-risk patients, report investigators in Schizophrenia Bulletin.

25 Oct 2013

Viewpoints: Republicans new-found interest in the workings of the health website; fixing the problem crucial to Obama's presidency

Republicans are apoplectic about Healthcare.gov, the official Web site for the Affordable Care Act. They are trying desperately to change the subject from their disastrous government shutdown by ranting about the failures of a government Web site that cost a tiny fraction of what was lost as a result of the shutdown. Republicans are pretending that they care about the problems encountered in signing up for a system that many of them are bent on destroying (Charles M. Blow, 10/23).

25 Oct 2013

Research unlocks secrets of mouse behavior to help identify promising psychiatric drugs

Developing psychiatric medications is a long and complex process. Candidate drugs are evaluated and assessed based on their effects on the behavior of animals, usually rats or mice. Each class of drugs, from antidepressants to antipsychotics, is tested differently - often in a labor-intensive process that leaves plenty of room for human error. And there is a growing consensus that current procedures fail to effectively produce new medications.

25 Oct 2013

Autoimmune link to schizophrenia

Patients with schizophrenia have an increased risk for developing autoimmune diseases, especially if they contract an infection, shows a registry-based study.

24 Oct 2013

Specific antibody patterns predict schizophrenia risk

The presence of antibodies to multiple foods and infectious agents is a risk marker for new-onset schizophrenia, a case-control study suggests.

23 Oct 2013

Scientists to converge at nation's first conference on computational psychiatry

More than 70 scientists from around the world and from a range of intellectual traditions will convene in Miami this week for what is believed to be the nation's first conference on computational psychiatry, an emerging field in neuroscience.

23 Oct 2013

Study identifies new genes involved in autism

A scientific study published on the journal Molecular Psychiatry identifies new genes involved in autism, a polygenic disorder that is difficult to diagnose and treat. Autism spectrum disorders represent a group of neurodevelopmental disorders which affect one out of 80-100 children.

23 Oct 2013

Study examines effectiveness of musical therapy for mental health care clients

A randomized controlled study published in the current issue of Psychotherapy and Psychosomatics has investigated the role of music therapy in the mental health of patients

23 Oct 2013

Gender differences in involuntary schizophrenia inpatients

The clinical characteristics of men and women who are involuntarily hospitalized for schizophrenia treatment differ from each other, leading to different management approaches, research shows.

22 Oct 2013

Professor wins Rhoda and Bernard Sarnat International Prize in Mental Health from Institute of Medicine

The Institute of Medicine today awarded the 2013 Rhoda and Bernard Sarnat International Prize in Mental Health to William T. Carpenter, professor of psychiatry and pharmacology at the University of Maryland School of Medicine, Baltimore.

22 Oct 2013

Schizophrenic hippocampal abnormalities blamed on glutamate

Elevated glutamate levels correlate with reduced tissue volume in the hippocampus of patients with schizophrenia, a study shows.

18 Oct 2013

Obesity may aggravate bipolar neuropathology

Being overweight may result in increased white matter loss in key brain regions in patients with bipolar disorder, research suggests.

18 Oct 2013

Cardiometabolic risk high for schizophrenia patients

The risk for abdominal obesity may be increased as much as fourfold for patients with multi-episode schizophrenia compared with the rest of the population, reveal findings from a meta-analysis.

17 Oct 2013

Scientists uncover faulty brain mechanism that may underlie schizophrenia in humans

Working with mice genetically engineered to display symptoms of schizophrenia, neuroscientists at the RIKEN-MIT Center for Neural Circuit Genetics at the Picower Institute for Learning and Memory at MIT have uncovered a faulty brain mechanism that may underlie schizophrenia and other psychiatric disorders in humans.

17 Oct 2013

Seven promising scientists named 2013 NYSCF - Robertson Investigators

The New York Stem Cell Foundation today named seven of the most promising scientists as its 2013 NYSCF - Robertson Investigators.

16 Oct 2013

Cash rewards encourage antipsychotic injection adherence

Offering “modest” financial incentives to patients receiving maintenance antipsychotic treatment by depot injection can encourage them to adhere to the regimen, shows a randomized trial.

15 Oct 2013

Kraepelin distinctions back in favor

Modern statistical methods support Kraepelin’s original distinction between schizophrenia and bipolar disorder, but not the more recent schizoaffective disorder category, say researchers.

11 Oct 2013

Researchers identify gene that orchestrates important branching of nerve fibers

Our ability to detect heat, touch, tickling and other sensations depends on our sensory nerves. Now, for the first time, researchers at Albert Einstein College of Medicine of Yeshiva University have identified a gene that orchestrates the crucially important branching of nerve fibers that occurs during development. The findings were published online today in the journal Cell.

11 Oct 2013

Alkermes' ALKS 5461 drug gets FDA Fast Track status for major depressive disorder

Alkermes plc today announced that the U.S. Food and Drug Administration has granted Fast Track status for ALKS 5461 for the adjunctive treatment of major depressive disorder in patients with an inadequate response to standard therapies.

10 Oct 2013

Heptares' StaR platform offers breakthrough solution to challenge associated with antibodies therapeutics

Heptares Therapeutics, the leading GPCR structure-guided drug discovery and development company, achieved the first research milestone in its antibody therapeutics alliance with MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX), announced in February 2013.

10 Oct 2013

Schizophrenia News and Research

Latest Schizophrenia News and Research

Psychosis prediction model could facilitate early intervention

Viewpoints: Republicans new-found interest in the workings of the health website; fixing the problem crucial to Obama's presidency

Research unlocks secrets of mouse behavior to help identify promising psychiatric drugs

Autoimmune link to schizophrenia

Specific antibody patterns predict schizophrenia risk

Scientists to converge at nation's first conference on computational psychiatry

Study identifies new genes involved in autism

Study examines effectiveness of musical therapy for mental health care clients

Gender differences in involuntary schizophrenia inpatients

Professor wins Rhoda and Bernard Sarnat International Prize in Mental Health from Institute of Medicine

Schizophrenic hippocampal abnormalities blamed on glutamate

Obesity may aggravate bipolar neuropathology

Cardiometabolic risk high for schizophrenia patients

Scientists uncover faulty brain mechanism that may underlie schizophrenia in humans

Seven promising scientists named 2013 NYSCF - Robertson Investigators

Cash rewards encourage antipsychotic injection adherence

Kraepelin distinctions back in favor

Researchers identify gene that orchestrates important branching of nerve fibers

Alkermes' ALKS 5461 drug gets FDA Fast Track status for major depressive disorder

Heptares' StaR platform offers breakthrough solution to challenge associated with antibodies therapeutics

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Schizophrenia News and Research

Latest Schizophrenia News and Research

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in